Approved Ligands

InformationSiponimod (BAF312) BAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits &gt:1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase

InformationSiponimod (BAF312) BAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits &gt:1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase

InformationSiponimod (BAF312) BAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits &gt:1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase

sitagliptin.

sitagliptin.

sitagliptin.

sitagliptin.

sitagliptin.

sitagliptin.

sitagliptin.

sitagliptin.

sitaxsentan.